影响甲基丙二酸血症患儿临床疗效及预后的分子生物学机制分析

郑雷; 童凡

doi:10.11852/zgetbjzz2015-23-11-15

PDF(387 KB)

中国儿童保健杂志 ›› 2015, Vol. 23 ›› Issue (11) : 1169-1171. DOI: 10.11852/zgetbjzz2015-23-11-15

综述与讲座

影响甲基丙二酸血症患儿临床疗效及预后的分子生物学机制分析

郑雷¹,童凡²

作者信息 +

文章历史 +

摘要

目前已报道有5种基因突变类型(mut⁰、 mut^-、 cblA、 cblB、 cblD2 )可导致甲基丙二酸血症,有4种基因突变类型(cblC、cblD、cblF、cblJ)可导致甲基丙二酸血症合并同型半胱氨酸尿症; cblX基因(HCFC1)突变导致X-连锁的甲基丙二酸血症合并同型半胱氨酸尿症。cblA型甲基丙二酸血症预后最好,cblC型甲基丙二酸血症合并同型半胱氨酸尿症是中国人群中多见的疾病类型。甲基丙二酸血症、甲基丙二酸血症合并同型半胱氨酸尿症患者的临床治疗效果及预后与基因型有密切联系。及早通过基因分型进行分子诊断,可以明确诊断,对指导治疗、判断预后以及对下一胎进行产前诊断具有重要意义。

关键词

甲基丙二酸血症 / 甲基丙二酸血症合并同型半胱氨酸尿症 / 基因型

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

郑雷,童凡. 影响甲基丙二酸血症患儿临床疗效及预后的分子生物学机制分析[J]. 中国儿童保健杂志. 2015, 23(11): 1169-1171 https://doi.org/10.11852/zgetbjzz2015-23-11-15

中图分类号： R179

参考文献

[1] Oberholzer VG,Levin B,Burgess EA,et al.Methylmalonic aciduria.An inborn error of metabolism leading to chronic metabolic acidosis[J].Arch Dis Child,1967,225:492-504.
[2] BrorkeMonsen AL,Ueland PM,Volset SE.Determinants of cobalamarnin status in newborns[J].Pediatrics,2001,108(3):624-630.
[3] Mudd SH,Levy HL,Skovby F.Disorders of transulfuration[M].//:CR Scriver,AL Beaudet,WS Sly,D Valle (Eds.) The metabolic and molecular bases of inherited disease.McGraw-Hill Publishing Co,New York,1995:1279-1327.
[4] 杨艳玲,张月华,袁向东.甲基丙二酸血症的诊断和治疗分析 [J].中华围产医学杂志,2000,(3):30-32.
[5] Atkinson C,Miousse IR,Watkins D,et al.Clinical,biochemical,and molecular presentation in a patient with the cblD-Homocystinuria inborn error of cobalamin metabolism [J].JIMD Rep,2014,17:77-81.
[6] Schiff M,Jean-Francois B,Tilea B,et al.Isolated remethylation disorders:do our treatments benefit patients[J].J Inherit Metab Dis,2011,34(1):137-145.
[7] Fowler B,Leonard JV,Baumgartner MR.Causes of and diagnostic approach to rnethylrnalonic acidurias[J].J Inherit Metab Dis,2008,31:350-360.
[8] Forny P,Froese DS,Suormala T,et al.Functional characterization and categorization of missense mutations that cause methylmalonyl-CoA mutase (MUT) deficiency[J].Hum Mutat,2014,35(12):1449-1458.
[9] Forny P,Froese DS,Suormala T,et al.Functional Characterization and Categorization of Missense Mutations that Cause Methylmalonyl-CoA Mutase (MUT) Deficiency[J].Hum Mutat,2014,35(12):1449-1458.
[10] Froese DS,Gravel RA.Genetic disorders of vitamin B12 metabolism:eight complementation groups--eight genes[J].Expert Rev Mol Med,2010,12:e37.
[11] 韩连书,毋盛楠,叶军,等.单纯型甲基丙二酸血症患者诊治分析 [J].中华医学遗传学杂志,2013,(5):589-593.
[12] Liu MY,Yang YL,Chang YC,et al.Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homoeystinuria[J].J Hum Genet,2010,55(9):621-626.
[13] WangF,Han LO,Yang Y,et al.Clinical biochemical and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China[J].J Inherit Metab Dis,2010,33 (Suppl 3):435-442.
[14] 刘玉鹏,马艳艳,吴桐菲,等.早发型甲基丙二酸尿症160例新生儿期异常表现[J].中华儿科杂志,2012,50(6):410-414.
[15] Morel CF,Lerner-Ellis JP,Rosenblatt DS.Combined methylmalonic aciduria and homocystinuria (cblC):phenotypegenotype correlations and ethnic-specific observations [J].Mol Genet Metab,2006,88(4):315-321.
[16] Gherasim C,Ruetz M,Li Z,et al.Pathogenic mutations differentially affect the catalytic activities of the human B12-processing chaperone CblC and increase futile redox cycling[J].J Biol Chem,2015,290(18):11393-11402.
[17] Rutsch F,Gailus S,Miousse IR,et al.Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism[J].Nat Genet,2009,41(2):234-239.
[18] Coelho D,Kim JC,Miousse IR,et al.Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism[J].Nat Genet,2012,44(10):1152-1155.
[19] Yu HC,Sloan JL,Scharer G,et al.An X-Linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1[J].Am J Hum Genet,2013,93(3):506-514.
[20] Huemer M,Bürer C,Jeina P,et al.Clinical onset and course,response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data[J].J Inherit Metab Dis.DOI 10.1007/s10545-014-9803-7.